{"title":"Injectable Porous Silicon Nanoparticles as a Plasma Cytokine Scavenger for Potentiating Cytokine Storm Syndrome Treatment","authors":"Ruogu Qi, Shengliang Li, Feng Li, Junhua Mai, Yu Wang, Guixian Zhu, Dechen Zhang, Zheng Li, Haifa Shen, Jianliang Shen, Xuewu Liu","doi":"10.1002/anbr.202370101","DOIUrl":null,"url":null,"abstract":"<p><b>Injectable Nanoparticles</b>\n </p><p>Appropriate materials for the efficient and selective capturing of plasma cytokines are urgently needed. In article number 2300037, Jianliang Shen, Xuewu Liu, and co-workers design injectable porous silicon particles (PSPs) as scavenging adsorbents. The fabricated PSPs feature high porosity for large pore volume and high specific surface area, and a longer body circulation time. To facilitate specific recognition of targeting biomacromolecules, antibodies are immobilized on the interior surface of the PSPs.\n\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"3 10","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202370101","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202370101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Injectable Nanoparticles
Appropriate materials for the efficient and selective capturing of plasma cytokines are urgently needed. In article number 2300037, Jianliang Shen, Xuewu Liu, and co-workers design injectable porous silicon particles (PSPs) as scavenging adsorbents. The fabricated PSPs feature high porosity for large pore volume and high specific surface area, and a longer body circulation time. To facilitate specific recognition of targeting biomacromolecules, antibodies are immobilized on the interior surface of the PSPs.
期刊介绍:
Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science.
The scope of Advanced NanoBiomed Research will cover the following key subject areas:
▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging.
▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications.
▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture.
▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs.
▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization.
▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems.
with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.